Search Results

FILTER BY

1 - 12 of 46 matches

Sort by:
  • NewsDaily News

    AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

    Michael O'Riordan

    August 26, 2024

  • PresentationTCT 2023

    TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

    Presenter:  

    Manasi Tannu

    October 26, 2023

  • PresentationTCT 2022

    TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

    Presenter:  

    Dennis Narcisse

    September 17, 2022

  • PresentationTCT 2022

    TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

    Presenter:  

    Alexander Fanaroff

    September 17, 2022

  • NewsConference NewsACC 2022

    Managing AF Patients Undergoing PCI—Some Lingering Questions

    Michael O'Riordan

    April 12, 2022

  • NewsDaily News

    Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

    Yael L. Maxwell

    April 9, 2021

  • NewsDaily News

    Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

    Todd Neale

    February 9, 2021

  • NewsDaily News

    ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

    Todd Neale

    December 22, 2020

  • NewsDaily News

    ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

    Michael O'Riordan

    September 16, 2020

  • NewsConference NewsESC 2020

    New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

    Caitlin E. Cox

    September 3, 2020

  • NewsConference NewsESC 2020

    Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care

    Shelley Wood

    August 30, 2020

  • NewsConference NewsACC 2020

    Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

    Todd Neale

    April 3, 2020